title: P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
authors.affiliation: Cancer and Leukemia Group B, Chicago, IL, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Kolitz
authors.forename: S L
authors.initials: SL
authors.lastname: George
authors.forename: M R
authors.initials: MR
authors.lastname: Baer
authors.forename: E J
authors.initials: EJ
authors.lastname: Lee
authors.forename: C D
authors.initials: CD
authors.lastname: Bloomfield
authors.forename: R A
authors.initials: RA
authors.lastname: Larson
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017326:Clinical Trials, Phase III as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000378:metabolism*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin